Two Sigma Advisers’s Patterson-UTI PTEN Stock Holding History

Two Sigma Advisers’s Portfolio PTEN Stock Details PTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-9,000	Closed	-$293K	–	2713
2014 Q3	$293K	Sell	9,000 -33,000	-79%	-$1.12M	﹤0.01%	1882
2014 Q2	$1.47M	Buy	+42,000	New	+$1.38M	0.01%	970

Other funds holding PTEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Two Sigma Advisers's PTEN Position: Q1 2026 in Review

Two Sigma Advisers sold out of Patterson-UTI (PTEN) in Q1 2026, closing a stake of 740,110 shares — an estimated $4.52M sold.

Two Sigma Advisers first reported a position in PTEN in Q4 2013 and held it in 37 quarters. The position peaked at $22.7M in Q1 2014. 410 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.

Two Sigma Advisers reported no remaining Patterson-UTI position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 740,110 Patterson-UTI shares in Q1 2026, an estimated $4.52M.
Two Sigma Advisers first reported a position in Patterson-UTI in Q4 2013 and held it in 37 quarters.
Two Sigma Advisers's Patterson-UTI position peaked at $22.7M in Q1 2014.
410 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.